NCI PMB

Name of Contracting Organization

Pharmaceutical Management Branch, Cancer Therapy Evaluation Program, National Cancer Institute

Contract Title

Support Services for the CTEP Pharmaceutical Management Branch

Period of Performance

September 1, 2022 – August 31, 2027

NAICS Code

541611

Advancing Cancer Treatment: Supporting NCI's Clinical Trials Network

Behind every breakthrough in cancer treatment lies an intricate network of operational support, regulatory compliance, and logistical coordination. Cancer research depends on complex clinical trials that can span years and involve thousands of participants across multiple countries. Each trial requires meticulous documentation, participant registration, and real-time communication between researchers, pharmaceutical companies, and regulatory bodies.

Since 2007, EDJ Associates, Inc. has served as part of the operational backbone for the National Cancer Institute’s Pharmaceutical Management Branch, supporting one of the world’s largest clinical trials networks through our contract support.

The Challenge

The NCI’s clinical trials network encompasses over 50,000 investigators across multiple countries, hundreds of active trials, and complex regulatory requirements. Each experimental cancer treatment requires meticulous tracking, documentation, and coordination—where operational errors could delay life-saving therapies.

EDJ Associates, Inc. Critical Role

Our specialized staff members manage four essential functions that keep cancer research moving:

Investigator Management: EDJ Associates, Inc. maintains credentials for investigators and co-investigators through the Registration and Credential Repository system, ensuring only qualified medical professionals participate in trials.
Drug Distribution: Processing clinical drug requests annually through sophisticated tracking systems, EDJ ensures experimental treatments reach the right patients at precisely the right time, coordinating both domestic and international distribution.
Communication Hub: EDJ Associates, Inc. answers phone calls and triages emails annually while distributing thousands of critical documents—including safety notifications, protocol updates, and investigator brochures—keeping all stakeholders informed.
Technology Management: EDJ Associates, Inc. operates multiple databases and identity management systems, providing quality assurance and helpdesk support that enables seamless data sharing across the research network.

Impact

EDJ Associates, Inc. Patient Consenting and Clinical Trial Recruitment Services enable more patients to discover and participate in clinical trials while helping healthcare providers better understand and promote NCI studies. By breaking down communication barriers and creating accessible consenting materials, EDJ Associates, Inc. directly contributes to advancing cancer treatment through increased trial participation and improved patient outcomes.

Key Differentiators

Successfully managed $13.9M Cost Plus Fixed Fee contract with demonstrated operational efficiency, cost control, and value delivery across comprehensive pharmaceutical distribution and administrative support services.

Demonstrated exceptional capability in managing complex, mission-critical operations requiring specialized expertise in pharmaceutical distribution, regulatory compliance, investigator credentialing, database management, and stakeholder engagement within the highly regulated clinical trials environment. The 18+ year partnership demonstrates sustained excellence in supporting NCI’s mission to advance cancer research through safe, efficient, and compliant investigational agent distribution to clinical trial sites nationwide and internationally.